The UK Medicines and Healthcare products Regulatory Agency (MHRA) isn't sufficiently funded to meet its obligations, according to a new report commissioned by a pharma trade organisation.
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has announced sweeping changes to regulations governing clinical trials, which it says are the largest in more than 20 years.
Market data, analyses and news for your industry.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback